Tumor News and Research

RSS

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

A robot could become the 'weapon' of choice for detecting and treating the most common cancer in men, improving results and reducing side effects.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research group led by Nuno Barbosa Morais, Group Leader at Instituto de Medicina Molecular João Lobo Antunes, and now published open access in Nucleic Acids Research.

4 Oct 2018

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

The presence of the human high-risk papillomavirus in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared with if high-risk HPV cannot be identified in the tumor, researchers at Karolinska Institutet in Sweden report in the scientific journal PLOS Medicine.

3 Oct 2018

Natural compound found in grapes may protect against cancer

Lung cancer is the deadliest form of cancer in the world, and 80% of death are related to smoking. In addition to tobacco control, effective chemoprevention strategies are therefore needed.

3 Oct 2018

Could 'natural adaptive therapies' be a better way to keep cancer under control?

While many cancer therapies initially can be very successful, tumors often return and spread when remaining cancer cells develop resistance to treatment.

3 Oct 2018

Combination approach appears to improve chemotherapy response, boost anti-tumor immunity

Scientists at the University of Toronto's Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response in pre-clinical model breast cancer.

3 Oct 2018

Changes in skin and lymphatic system due to age facilitate melanoma metastasis

Changes in the structure of the skin and the lymphatic system that occur with the natural aging process create permissive conditions for melanoma metastasis, according to two studies by The Wistar Institute.

3 Oct 2018

New way of using natural killer cells makes immunotherapy viable to more patients

Immunotherapy is making headlines for saving the lives of hundreds of cancer patients including former President Jimmy Carter. But many of these therapies, only work for a small portion of people who have a specific molecule called PDL1 in their cancer makeup.

3 Oct 2018

Aggressive breast cancer hijacks normal protective physiological process to survive

A member of a protein family known for protecting our cells also protects cancer cells in aggressive, metastatic breast cancer, scientists report.

3 Oct 2018

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

SCIENTISTS fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer reoccurrence in patients after surgery.

3 Oct 2018

Aggressive breast cancer cells hijack protective protein to aid growth

A new study has revealed that a protein known to protect healthy cells also protects cancer cells in aggressive breast cancer.

2 Oct 2018

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

1 Oct 2018

Study using DFMO shows positive results for children with high risk neuroblastoma

A paper published September 27 in Scientific Reports shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in children with High Risk Neuroblastoma.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 1 in the journal Nature Communications.

1 Oct 2018

Gangrene-causing bacteria show promise as cancer treatment

Researchers have found that the bacteria responsible for causing gangrene could also be used to treat patients with certain cancers.

1 Oct 2018

'Kidney-gene' plays role in the central nervous system and controls movement

The WT1 gene fulfills a central role in the development of a healthy, proper functioning kidney. Mutations in WT1 lead to impairments in kidney development and cause Wilms tumors, a pediatric kidney cancer.

1 Oct 2018

International conference features cutting-edge research studies on cancer immunotherapy

The Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, to be held in New York, Sept. 30-Oct. 3, will feature cutting-edge research studies from around the world that endeavor to answer urgent questions in the field of cancer immunotherapy to advance progress more rapidly for patients.

1 Oct 2018

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

1 Oct 2018

Tumor News and Research

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

Presence of high-risk HPV in cervical cancer diagnosis linked to improved prognosis

Natural compound found in grapes may protect against cancer

Could 'natural adaptive therapies' be a better way to keep cancer under control?

Combination approach appears to improve chemotherapy response, boost anti-tumor immunity

Changes in skin and lymphatic system due to age facilitate melanoma metastasis

New way of using natural killer cells makes immunotherapy viable to more patients

Aggressive breast cancer hijacks normal protective physiological process to survive

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Aggressive breast cancer cells hijack protective protein to aid growth

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Study using DFMO shows positive results for children with high risk neuroblastoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

Gangrene-causing bacteria show promise as cancer treatment

'Kidney-gene' plays role in the central nervous system and controls movement

International conference features cutting-edge research studies on cancer immunotherapy

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News